TSHA icon

Taysha Gene Therapies
TSHA

Overview Fund Activity

54 hedge funds and large institutions have $27M invested in Taysha Gene Therapies in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 22 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
54
Holders Change
-5
Holders Change %
-8.47%
% of All Funds
0.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
11
Reduced
22
Closed
8
Calls
$191K
Puts
–
Net Calls
+$191K
Net Calls Change
+$102K

Top Buyers

1
QPW
Quantum Private Wealth
Florida
$442K
2
BCM
Bridgeway Capital Management
Texas
$270K
3
GCP
GSA Capital Partners
United Kingdom
$456K
4
CC
Carlson Capital
Texas
$386K
5
CIC
Cornercap Investment Counsel
Georgia
$105K

Top Sellers

1
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
$86K
2
Marshall Wace
Marshall Wace
United Kingdom
$0
3
Renaissance Technologies
Renaissance Technologies
New York
$808K
4
UBS Group
UBS Group
Switzerland
$12K
5
Charles Schwab
Charles Schwab
California
$32K
Name Holding Trade Value Shares
Change 		Shares
Change %
CUAMC
51
China Universal Asset Management Company
China
$1K +$1K +385 New
Marshall Wace
52
Marshall Wace
United Kingdom
– -$341K -91,670 Closed
DC
53
Davenport & Co
Virginia
– -$101K -27,170 Closed
Susquehanna International Group
54
Susquehanna International Group
Pennsylvania
– -$79K -21,163 Closed
TI
55
Trexquant Investment
Connecticut
– -$73K -19,548 Closed
AQR Capital Management
56
AQR Capital Management
Connecticut
– -$38K -10,134 Closed
CAPTRUST Financial Advisors
57
CAPTRUST Financial Advisors
North Carolina
– -$3K -821 Closed
New York State Common Retirement Fund
58
New York State Common Retirement Fund
New York
– -$1K -191 Closed
1 2
3